Targeting the SH2-Kinase Interface in BCR-Abl Inhibits Leukemogenesis

Cell - United States
doi 10.1016/j.cell.2011.08.046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

The Chimeric Ubiquitin Ligase SH2-U-box Inhibits the Growth of Imatinib-Sensitive and Resistant CML by Targeting the Native and T315i-Mutant BCR-ABL

Scientific Reports
Multidisciplinary
2016English

NPB001-05 Inhibits BCR-Abl Kinase Leading to Apoptosis of Imatinib-Resistant Cells

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Kinase Domain Mutants of BCR Enhance BCR-Abl Oncogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Simultaneous Targeting of Aurora Kinases and BCR-Abl Kinase by the Small Molecule Inhibitor PHA-739358 Is Effective Against Imatinib-Resistant BCR-ABL Mutations Including T315I

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Multidomain Targeting of BCR-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy